Cargando…

Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review

Defective interfering particles (DIPs) are particles containing defective viral genomes (DVGs) generated during viral replication. DIPs have been found in various RNA viruses, especially in influenza viruses. Evidence indicates that DIPs interfere with the replication and encapsulation of wild-type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Min, Zhou, Entong, Sheng, Rui, Fu, Xiaoshu, Li, Jiemin, Jiang, Chunlai, Su, Weiheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781619/ https://www.ncbi.nlm.nih.gov/pubmed/36560777 http://dx.doi.org/10.3390/v14122773

Ejemplares similares

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity
por: Bdeir, Najat, et al.
Publicado: (2021)

The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms
por: Yang, Yicheng, et al.
Publicado: (2019)

Influenza virus DI particles: Defective interfering or delightfully interesting?
por: Alnaji, Fadi G., et al.
Publicado: (2020)

Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy
por: Liu, Hongtao, et al.
Publicado: (2022)

(In)validating experimentally derived knowledge about influenza A defective interfering particles
por: Liao, Laura E., et al.
Publicado: (2016)

Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles
por: Fonville, Judith M., et al.
Publicado: (2015)

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
por: Dogra, Tanya, et al.
Publicado: (2023)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro
por: Pelz, Lars, et al.
Publicado: (2023)

Defective interfering particles of mouse hepatitis virus
por: Makino, Shinji, et al.
Publicado: (1984)

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity
por: Rand, Ulfert, et al.
Publicado: (2021)

Defective Interfering Viral Particles in Acute Dengue Infections
por: Li, Dongsheng, et al.
Publicado: (2011)

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles
por: Frensing, Timo, et al.
Publicado: (2013)

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

Experimental and mathematical insights on the interactions between poliovirus and a defective interfering genome
por: Shirogane, Yuta, et al.
Publicado: (2021)

Defective interfering virus protects elderly mice from influenza
por: Scott, Paul D, et al.
Publicado: (2011)

Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs
por: Makino, Shinji, et al.
Publicado: (1988)

Inhibition of infection spread by co-transmitted defective interfering particles
por: Baltes, Ashley, et al.
Publicado: (2017)

Modeling the therapeutic potential of defective interfering particles in the presence of immunity
por: Karki, Bandita, et al.
Publicado: (2022)

A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome
por: Kupke, Sascha Young, et al.
Publicado: (2019)

A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral
por: Smith, Claire M., et al.
Publicado: (2016)

Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence
por: Manzoni, Tomaz B, et al.
Publicado: (2018)

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA
por: Meng, Bo, et al.
Publicado: (2017)

Population dynamics of an RNA virus and its defective interfering particles in passage cultures
por: Thompson, Kristen A Stauffer, et al.
Publicado: (2010)

Evolution of naturally arising SARS-CoV-2 defective interfering particles
por: Girgis, Samer, et al.
Publicado: (2022)

Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection in vitro and in vivo
por: Huang, Xinyu, et al.
Publicado: (2022)

Interfering antiviral immunity: application, subversion, hope?
por: Manjunath, N., et al.
Publicado: (2006)

Design of Small Interfering RNAs for Antiviral Applications
por: Rothe, Diana, et al.
Publicado: (2010)

Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection
por: Lin, Min-Hsuan, et al.
Publicado: (2022)

SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection
por: Lui, Wing-Yu, et al.
Publicado: (2019)

Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles
por: Poirier, Enzo Z., et al.
Publicado: (2016)

Collective Viral Spread Mediated by Virion Aggregates Promotes the Evolution of Defective Interfering Particles
por: Andreu-Moreno, Iván, et al.
Publicado: (2020)

Patch formation driven by stochastic effects of interaction between viruses and defective interfering particles
por: Liang, Qiantong, et al.
Publicado: (2023)

Recombination and Coronavirus Defective Interfering RNAs()
por: Brian, David A., et al.
Publicado: (1997)

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
por: Hein, Marc D., et al.
Publicado: (2021)

Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses
por: Vasou, Andri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_reekjkcsqhofr80mu07qgbkr70